Eli Lilly accuses church bishops, businessmen of fraud in Trulicity drug rebate scheme
Eli Lilly has filed a lawsuit accusing several church bishops and businessmen of orchestrating a fraudulent scheme to steal over $200 million in rebates related to its diabetes medication, Trulicity. The lawsuit claims that a Florida pharmacy, DrugPlace, falsely reported dispensing the medication to church members while actually selling it on the secondary market. Lilly is seeking legal action against the involved parties to halt the alleged fraud and protect patients.
- ▪Eli Lilly alleges that DrugPlace and affiliated church members engaged in a scheme to defraud the company of over $200 million in drug rebates.
- ▪The lawsuit claims that DrugPlace submitted fraudulent rebate claims for Trulicity, with many patients tied to those claims either non-existent or unverifiable.
- ▪Lilly's investigation revealed unusual patterns in rebate claims, indicating potential fraud over a period of at least six years.
Opening excerpt (first ~120 words) tap to expand
Eli Lilly says it has uncovered a long-running scheme to steal more than $200 million in rebates from its diabetes medication, Trulicity, accusing several bishops at a major Pentecostal church of fraud.The company filed a 66-page civil lawsuit Tuesday in U.S. District Court in Miami.Here's how the scheme worked, according to Lilly: A Florida mail-order pharmacy called DrugPlace bought large quantities of Trulicity for years through authorized distributors, claiming the drugs were dispensed to patients who were members of the church. But Lilly alleges that in reality DrugPlace sold the Trulicity on the secondary market at the same time it was collecting fraudulent rebates from Lilly.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at US Top News and Analysis.
Discussion
0 commentsMore from US Top News and Analysis
